What Should We Do About Heart Failure: Challenges for 2009
Key result
Despite available life-prolonging therapies for chronic heart failure, surveys indicate suboptimal implementation, with only 20% of patients receiving target doses of ACE inhibitors and beta-blockers.
Population
Physicians treating chronic heart failure (CHF) and their patients
Design
Editorial
Authors
Discussion
Loading...
Member takes
Implication
The major challenge in heart failure management is not discovering new treatments, but effectively implementing existing, life-prolonging guideline-directed therapies.
Structured PICO
P
Population
Physicians treating chronic heart failure (CHF) and their patients
I
Intervention
Implementation of guideline-directed medical therapy (ACE inhibitors, beta-blockers, devices)
The major challenge in heart failure management is not discovering new treatments, but effectively implementing existing, life-prolonging guideline-directed therapies.
Cite This Study
Karl Swedberg (2009) conducted an editorial in Chronic heart failure. Despite available life-prolonging therapies for chronic heart failure, surveys indicate suboptimal implementation, with only 20% of patients receiving target doses of ACE inhibitors and beta-blockers.